- Trials with a EudraCT protocol (398)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (21)
398 result(s) found for: Allergen.
Displaying page 1 of 20.
EudraCT Number: 2013-005394-45 | Sponsor Protocol Number: MM09-STD-011 | Start Date*: 2015-09-03 | |||||||||||
Sponsor Name:Inmunotek, S.L. | |||||||||||||
Full Title: Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen extract. Determination of the allergenic potency in vivo histamine equivalent units (HEP) | |||||||||||||
Medical condition: Allergy to mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005368-24 | Sponsor Protocol Number: T502-SSP-007 | Start Date*: 2014-06-30 | |||||||||||
Sponsor Name:INMUNOTEK, S.L. | |||||||||||||
Full Title: Extract allergen from Betula verrucosa. Test sensitivity and specificity of diagnostic in prick test preparation. | |||||||||||||
Medical condition: Allergy to Betula verrucosa | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002678-19 | Sponsor Protocol Number: SP148MP201 | Start Date*: 2018-03-20 | |||||||||||
Sponsor Name:SmartPractice | |||||||||||||
Full Title: Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study | |||||||||||||
Medical condition: Metal induced contact dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002915-24 | Sponsor Protocol Number: 0178 | Start Date*: 2019-10-24 | |||||||||||
Sponsor Name:Theravance Biopharma Ireland Limited | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, 3-period Crossover Study to Evaluate the Effects of Repeated Doses of Inhaled TD-8236 and Impact on Airway Responses Following Allergen Challenge in ... | |||||||||||||
Medical condition: Treatment of airway inflammation, initially in asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000684-10 | Sponsor Protocol Number: ME3301-12 | Start Date*: 2004-10-28 |
Sponsor Name:Meiji Seika Kaisha, Ltd. | ||
Full Title: A randomised, double-blind, placebo-controlled crossover study to investigate the efficacy and safety of three doses of ME3301 in patients with seasonal allergic rhinitis during allergen challenge ... | ||
Medical condition: seasonal allergic rhinitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002477-22 | Sponsor Protocol Number: R1908-1909-ALG-1703 | Start Date*: 2019-01-25 | ||||||||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY IN CAT-ALLERGIC PATIENTS WITH ASTHMA TO EVALUATE THE EFFICACY OF A SINGLE DOSE OF REGN1908-1909 TO REDUCE BRONCHOCONSTR... | ||||||||||||||||||
Medical condition: Cat-allergic asthma and Bronchoconstriction Upon Cat Allergen Challenge | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003846-29 | Sponsor Protocol Number: 01.1.1.H3 | Start Date*: 2015-01-20 | |||||||||||
Sponsor Name:Revalesio Corporation | |||||||||||||
Full Title: A Phase IIA randomized, double-blind, placebo controlled, cross-over study to evaluate the effects of multiple doses of inhaled RNS60 and Budesonide on the late phase asthmatic response to allergen... | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-007096-32 | Sponsor Protocol Number: PREV1234 | Start Date*: 2009-01-07 |
Sponsor Name:Medizinische Universität Wien, Univ. Kinderklinik | ||
Full Title: Prevention od new sensitization by sublingual immunotherapy in children 2-4 years of age with allergic mono-sensitization | ||
Medical condition: Children (2-4years of age) from atopy prone families with an allergic sensitization as defined by positive skin prick test or positive allergen-specific IgE to grass pollen or house dust mite aller... | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005838-12 | Sponsor Protocol Number: OC000459/004/05 | Start Date*: 2006-03-30 | |||||||||||
Sponsor Name:Oxagen Ltd | |||||||||||||
Full Title: A PHASE II STUDY OF THE EFFICACY (AS ASSESSED BY BRONCHIAL ALLERGEN CHALLENGE) AND SAFETY OF OC000459 DOSED ORALLY (200mg BID WITH FOOD) IN SUBJECTS WITH ALLERGIC ASTHMA; IN A RANDOMISED, DOUBLE BL... | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002872-41 | Sponsor Protocol Number: ELR100710 | Start Date*: 2005-10-18 |
Sponsor Name:GlaxoSmithKline Research & Development Limited | ||
Full Title: A Study to Validate Key Therapeutic Targets and Biomarkers during Allergen Exposure in Subjects with Allergic Rhinitis | ||
Medical condition: Seasonal allergic rhinitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016815-39 | Sponsor Protocol Number: il-ASIT1 | Start Date*: 2010-01-15 |
Sponsor Name:Allergy Unit Department of Oto-rhino-Laryngology Lund/Malmö University Hospital | ||
Full Title: Is Intralymphatic Allergen Immunotherapy effective and safe: A human randomized clinical trial | ||
Medical condition: Seasonal Allergic rhinitis due to pollen from grass and betula verrucosa | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020079-22 | Sponsor Protocol Number: DG40.08 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:STALLERGENES S.A. | |||||||||||||
Full Title: Determination of sensitivity and specificity of five solutions of allergen extract (5 grasses, birch, ragweed pollens and Dermatophagoides pteronyssinus and Dermatophagoides farinae mites) for diag... | |||||||||||||
Medical condition: Allergy to grass pollen Allergy to birch pollen Allergy to ragweed pollen Allergy to mites | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001880-68 | Sponsor Protocol Number: 1001-PR-PRI-133 | Start Date*: 2005-09-23 |
Sponsor Name:LETI Pharma GmbH | ||
Full Title: Standardization of Latex allergenic extract. Determination of biological activity in HEP units | ||
Medical condition: The objective of the study is to know the biologic activity of the Latex reference extract (IHRP) in HEP units. The HEP value will be the reference of every other diagnostic or treatment preparations. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001729-28 | Sponsor Protocol Number: IPI-145-03 | Start Date*: 2012-07-17 | |||||||||||
Sponsor Name: Infinity Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Dose, Cross-Over, Efficacy and Safety Study of IPI-145 in Mild Asthmatic Subjects Undergoing Allergen Challenge | |||||||||||||
Medical condition: Mild asthma with allergen challenge | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000576-13 | Sponsor Protocol Number: INO102141 | Start Date*: 2004-11-03 |
Sponsor Name:GlaxoSmithKline Research & Development Limited | ||
Full Title: A two-centre, randomised, double-blind, double-dummy, placebo-controlled, 3-period cross-over study to evaluate the effect of treatment with repeat doses of GW274150 on the allergen-induced late as... | ||
Medical condition: Mild asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001762-14 | Sponsor Protocol Number: 69765 | Start Date*: 2020-07-29 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Evaluation of the anti-inflammatory effects of glycopyrronium added to indacaterol/mometasone on the allergen-induced late asthmatic response | ||
Medical condition: Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001957-34 | Sponsor Protocol Number: IIBSP-PBF-2015-34 | Start Date*: 2015-09-14 | |||||||||||
Sponsor Name:Palobiofarma S.L. | |||||||||||||
Full Title: A single-centre, randomised, double-blind, placebo-controlled, cross-over study to assess the efficacy of a 5-day, once daily 10-mg PBF-680 oral administration course to attenuate allergen bronchop... | |||||||||||||
Medical condition: Treatment for asthma. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000617-20 | Sponsor Protocol Number: SMART_2 | Start Date*: 2013-08-23 | |||||||||||
Sponsor Name:Lofarma S.p.A. | |||||||||||||
Full Title: A Dose Finding Study of the Efficacy of LAIS® Mites Sublingual tablets in patients suffering from house dust mite-induced allergic rhinoconjunctivitis A prospective, double-blind, placebo-controlle... | |||||||||||||
Medical condition: Patients suffering from allergic rhinoconjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001454-77 | Sponsor Protocol Number: VO57.07 | Start Date*: 2007-09-12 | |||||||||||
Sponsor Name:Stallergenes S.A | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, multi-national Phase II/III study of the safety and efficacy of two doses of sublingual immunotherapy (SLIT) administered as allergen-based tablets o... | |||||||||||||
Medical condition: House dust mite allergic rhinitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FR (Completed) DE (Completed) ES (Completed) NL (Completed) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004614-16 | Sponsor Protocol Number: DIA-ALE-2004-01 | Start Date*: 2005-09-29 |
Sponsor Name:DIATER LABORATORIES S.A. | ||
Full Title: Alternaria alternata inmunotherapy effects on AMP and methacholine bronchial answer and on inflammation markers in exhaled air (nitric oxide) and in condensated air (pH and hydrogen peroxide) in a... | ||
Medical condition: Asthma and allergic rhinitis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.